Navigation Links
Existence Genetics is Pioneering the Field of Predictive Medicine - Nexus Technologies Critical in Understanding and Preventing Deadly Disease
Date:5/20/2010

Through Existence’s cutting-edge technological advancements, prediction and prevention of a wide range of both common and rare diseases are possible before they ever manifest. The future of medicine starts today.

(PRWEB) May 20, 2010 -- Welcome your new Existence! Existence Genetics LLC, the world’s first predictive medicine company, is working with healthcare providers to PREDICT, PREVENT, and PREVAIL over disease.

Founded in 2005 by a team of physicians, Existence Genetics is pioneering the field of predictive medicine by providing Genetically Tailored Technology to the health care industry. Existence provides health care professionals with access to groundbreaking predictive medicine services and delivers understandable, useful, and personalized solutions to protect and preserve their patients’ health. Rather than simply handing bewildering results to an untrained patient, the goal of Existence is to empower health care professionals with genetic technology so that they can efficiently integrate genetic screening into their practice and provide cutting-edge predictive medicine services to their patients. Because of this, Existence provides its services only through health care professionals and not direct to the consumer (DTC) or over the counter (OTC).

Existence has developed patent-pending Nexus technologies to enable comprehensive genetic testing and analysis that focuses on the personalized prevention of disease. The Nexus technologies include a proprietary, highly advanced gene chip known as the Nexus Gene Chip. This first-of-its-kind, highly accurate gene chip allows cost-effective, time-efficient screening for hundreds of potential disease predispositions as well as for genes that are involved in the prevention and treatment of disease, thereby enabling the advent of genetically tailored prevention. The results provided by the Nexus Gene Chip are analyzed by the Nexus IT system, which uses patent-pending technologies such as the disease matrix, reflex analysis, panel screening, and next-generation genetic reports to provide health care professionals with straightforward, genetically-tailored solutions for their patients.

Existence’s Nexus technologies make predictive medicine straightforward, understandable, useful, and personalized. Existence’s One Genome philosophy means that we focus on all diseases regardless of their prevalence and screen simultaneously for hundreds of rare and common diseases. And because its Nexus technologies were developed with this philosophy in mind, Existence will be the first company that is able to provide full genome clinical analysis of full genome sequencing data.

In addition, Existence’s newest technology, the Pythia Approach, which is now in its final stages of development, combines the genetic analysis of two potential parents to determine the disease predispositions and traits their yet-to-be-conceived offspring are likely to inherit.

Through Existence’s cutting-edge technological advancements, prediction and prevention of a wide range of both common and rare diseases are possible before they ever manifest. The future of medicine starts today.

Existence Genetics has offices in California and New York, with headquarters in Los Angeles. To learn more about Existence Genetics and the Nexus technologies, visit www.existencegenetics.com.

###

Read the full story at http://www.prweb.com/releases/existencegenetics/may2010/prweb4025124.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Georgia DUI Lawyers Scramble to Publicize Existence of New Appeal Fee of $150 for All DUI-Related Administrative License Suspension Cases
2. Medco Acquires Leading Genetics Healthcare Company, DNA Direct
3. New License Agreement with University of Colorado Gives Viral Genetics, Inc., Right to Develop Cancer Therapies
4. Chicago Cancer Genome Project studies genetics of 1,000 tumors
5. Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New York
6. Interleukin Genetics, Inc. and Stanford University Report Genetic Test Improves Weight Loss Success With Diets
7. Study finds changes in fetal epigenetics throughout pregnancy
8. Genetics, Psychology May Trigger ADHD
9. Resveratrol Supplement Company RevGenetics Welcomes New Chief Science Officer
10. Mount Sinai School of Medicine Commencement Honors Leaders in Genetics and Global Health
11. Cancer genetics pioneer wins Margaret Kripke Legend Award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Existence Genetics is Pioneering the Field of Predictive Medicine -  Nexus Technologies Critical in Understanding and Preventing Deadly Disease 
(Date:2/10/2016)... FL (PRWEB) , ... February 10, 2016 , ... AxoGen, ... market, will report results for the fourth quarter and full year ended December 31, ... host a conference call and webcast for the investment community following the release at ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: The ... and inspirational speaker Jan Fox will serve as keynote speaker at the organization’s ... participants with tools to more effectively communicate with their own organizational staff and ...
(Date:2/10/2016)... ... February 10, 2016 , ... For additional information contact Phyllis Strupp ... book "Better with Age: The Ultimate Guide to Brain Training" by award-winning author ... The book’s publication date is March 16, 2016. A free review copy is ...
(Date:2/10/2016)... Beach, Florida (PRWEB) , ... February 10, 2016 ... ... Country Club) announced that it has been awarded the prestigious Distinguished Emerald Club ... World award program conducted by BoardRoom magazine, one of the most respected trade ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... biocompatible columns and accessories. These PEEK-lined stainless steel (PLS) columns combine the strength ... solution that ensures the integrity of biological samples while operating at ultra-high pressures ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... -- Urologix, the market leader for in-office minimally invasive ... (BPH), announces new private ownership and is operating as ... industry veteran of more than 20 years, has been ... Plymouth, Minn. The company,s two ... RF Therapy, will continue to be broadly available and ...
(Date:2/10/2016)... Feb. 10, 2016  Rich Pharmaceuticals, Inc. (OTC Markets: ... 1-for-100 reverse split of its issued and outstanding shares ... on Thursday, February 11, 2016. The Company,s common stock ... number 76303T308 and temporary ticker symbol "RCHAD". After 20 ... the ticker symbol (RCHA).  --> ...
(Date:2/10/2016)... 10, 2016  Oxis International Inc. (OTC/QB: OXIS) announced ... described as a "clinical trial triumph" after one of ... complete cancer remission. Daniel Vallera , ... Cancer Center. --> Daniel Vallera , ... Cancer Center. --> An article on ...
Breaking Medicine Technology: